Abstract: Techniques or processes for providing markings on products are disclosed. The markings provided on products can be textual and/or graphic. The techniques or processes can provide high resolution markings on surfaces that are flat or curved. In one embodiment, the products have housings and the markings are to be provided on the housings. For example, the housing for a particular product can include an outer housing surface and the markings can be provided on the outer housing surface.

Abstract: A prevention-based network auditing system includes a central compliance server generating network policies and configuring audits of the data communications network. The compliance server presents a graphical user interface (GUI) to describe the specific data gathering parameters, policies to be analyzed, and the schedule of analysis. One or more audit servers strategically deployed around the network employ heterogeneous data-gathering tools to gather information about the network in response to the configured audits, and transmit the gathered information to the compliance server. An audit repository stores the gathered information for use by the compliance server for security and regulatory policy assessment, network vulnerability analysis, report generation, and security improvement recommendations.

Abstract: A rotary burr comprising cemented carbide for removing material from a workpiece includes a shank and a working portion and a shank. A surface of the working portion includes a plurality of right-handed helically oriented flutes that define a plurality of cutting teeth on the working portion. Each of the plurality of cutting teeth defined by the right-handed flutes includes a front face, a back face, a tip, and a positive front face angle, and lacks a radial land adjacent the tooth tip and at the periphery of the working portion.

Abstract: A prevention-based network auditing system includes a central compliance server storing both natural language policy documents and machine-processable policy rules in an audit repository. The compliance server provides a client-side user interface allowing a user to easily generate a machine-auditable policy by selecting/generating a natural language policy source document, and linking the applicable machine-processable policy rules to the applicable portions of the source document. The selected machine-processable policy rules are then applied to information gathered about the network during a scheduled network audit session for efficiently and systematically determining whether policy violations and/or vulnerabilities exist.

Abstract: A flow generator for delivering breathable gas to a patient includes a processor coupled with operation sensors and a user interface. The processor is programmed to generate at least one of time-based or event-based messages relating to at least one of flow generator operation, flow generator service, flow generator use, patient health, peripheral devices and services, patient treatment, and reminders. Time-based messages are generated at predetermined time intervals based on either time of use or elapsed time. The event-based messages are generated based on signals from the operation sensors. The user interface is configured to deliver the messages to at least one of a display, a flow generator service provider, the patient and a physician. By this system, operation of the flow generator is facilitated and enhanced.

Abstract: A system and method are provided for organizing and loading orthodontic appliances, for example orthodontic brackets, onto set-up trays. The system includes an organizer tray which holds a set-up tray in a fixed orientation, and also holds a plurality of packages of orthodontic brackets in predetermined relationships to bracket staging areas on the set-up tray. Bracket packages and the organizer tray are configured so that the brackets are presented in the same orientation, when in their packages held by the organizer tray, as they will have when transferred to the set-up tray. As a result, the brackets can be loaded onto the set-up tray from the packages without re-orientation. The organizer tray has a storage base that holds supplies of packages of the different brackets of a given set so that the organizer tray can be reloaded with packages. Preferred organizer tray and package configurations are also provided.

Abstract: There are provided according to the invention compounds of formula (I) wherein R1 represents C1-6 alkyl or C1-6 haloalkyl; R2 represents —C(?O)-aryl or —C(?O)-heteroaryl; R3 represents hydrogen, methyl (which may be in either the ? or ? configuration) or methylene; R4 and R5 are the same or different and each represents hydrogen or halogen; and——represents a single or a double bond; and salts and solvates thereof. There are also provided processes for preparing compounds of formula (I) and use of the compounds in therapy especially in the treatment of inflammatory and allergic conditions.

Abstract: A method for determining an RF link imbalance between an Uplink Path and a Downlink Path of an RF Link formed between a User Equipment (UE) and a Node in a wireless network is provided. The method includes determining the UE receive power levels and the UE transmit power levels for the RF Links at the UE side of the radio interface and identifying one or more RF Links having AvgSumTx+Rx values deviating from the AvgSumTx+Rx values of other RF Links, as one or more RF Links having an RF Link imbalance.

Abstract: There are provided according to the invention pharmaceutical compositions comprising a compound of formula (I) wherein R1 represents C1-6 alkyl or C1-6 haloalkyl; R2 represents —C(?O)-aryl or —C(?O)-heteroaryl, wherein said heteroaryl is a 5 member heterocyclic aromatic ring containing 1-3 hetero atoms selected from N and S, or a 5 member heterocyclic aromatic ring containing 2-3 hetero atoms selected from N, O and S, or a 6 member heterocyclic aromatic ring containing 1-3 hetero atoms selected from N, O and S; R3 represents hydrogen, methyl (which may be in either the ? or ? configuration) or methylene; R4 and R5 are the same or different and each represents hydrogen or halogen; and represents a single or a double bond; or a physiologically acceptably salt or solvate thereof; and another therapeutically active agent; in admixture with one or more physiologically acceptable diluents or carriers.

Abstract: A process for the production of acetic acid by carbonylating methanol and/or a reactive derivative thereof with carbon monoxide in the presence of a promoted iridium carbonylation catalyst wherein the promoters are boron and gallium.

Abstract: A gesture recognition engine and method provides for recognition of gestures comprising movement of an object. Input data is received related to a succession of positions, velocities, accelerations and/or orientations of the at least one object, as a function of time, which input defines a trajectory of the at least one object. Vector analysis is performed on the trajectory data to determine a number N of vectors making up the object trajectory, each vector having a length and a direction relative to a previous or subsequent vector or to an absolute reference frame, the vectors defining an input gesture signature. The input gesture signature is compared, on a vector by vector basis, with corresponding vectors of a succession of library gestures stored in a database, to identify a library gesture that corresponds with the trajectory of the at least one object.

Abstract: There are provided compounds of formula (I) wherein R1 represents O, S or NH; R2 represents —C(?O)-aryl or —C(?O)-heteroaryl; R3 represents hydrogen, methyl (which may be in either the ? or ? configuration) or methylene; R4 and R5 are the same or different and each represents hydrogen or halogen; and represents a single or a double bond; and salts and solvates thereof; process for preparing them, compositions containing them and their use in therapy.

Abstract: The invention is directed to certain novel compounds. Specifically, the invention is directed to compounds according to formula (I): and salts thereof. The compounds of the invention are inhibitors of kinase activity, in particular IKK2 activity.

Abstract: The invention is directed to certain novel compounds. Specifically, the invention is directed to compounds according to formula (I): and salts thereof. The compounds of the invention are inhibitors of kinase activity, in particular IKK2 activity.

Abstract: Remote controls that are configured to prevent inadvertent signal transmission.

Abstract: Remote controls that are configured to prevent inadvertent signal transmission.

Abstract: A flow generator and humidifier construction is described, including a flow generator construction adapted to reduce noise output compared to known flow generators of comparable size. The flow generator includes a chassis forming first and second muffler volumes and a venturi-shaped connection portion, and a metal/polymer composite material blower enclosure which suppresses noise from the blower. The flow generator may be programmed to include a reminder system including a menu from which the user may request a reminder to take specific action, e.g., replace a component, call a physician, and/or enter patient data card, etc.

Abstract: A composition for inhibiting the growth of microorganisms on non-cellulosic fibres having a moisture regain of ?5%, comprising; 1) 1 to 50 wt % of at least a self-crosslinkable resin: ii) 0.25 to 20 wt % of at least a catalyst; iii) 0.1 to 4 wt % of at least an antimicrobial active agent, reactive with the resin; iv) 98.65 to 26 wt % of water; wherein i)+ii)+iii)+iv)=100%.

Abstract: A fence system, and method for making same, includes at least one support member, and at least one infill material having an edge. At least one union strip is coupled to the at least one support member, the at least one union strip including at least one channel configured for receiving the edge of the at least one infill material. In one embodiment of the invention, the at least one channel is U-shaped, and the edge is configured in a U-shape for matingly engaging the at least one U-shaped channel.

Abstract: There are provided compounds of formula (I) wherein the variables are as defined by the present specification; and solvates thereof, processes for preparing them and their use in therapy.